About this trial
The aim of this project is to compare the ovarian hormone levels 7 days after ovulation and progesterone:oestradiol ratios between PMDD individuals and a control cohort (case control study).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 18-45 years old (adults but less than the typical perimenopausal age so there is not added bias/variable)
Regular menstrual cycles (21-35 days for the last 3 months)
Willing and able to complete a questionnaire (no new clinical diagnosis given)
Use home urine LH test strips to detect ovulation
Disqualifiers
Current use or use in the last 3 months of hormonal contraception such as the combined oral contraceptive pill, the progestogen only pill, the implant, the injection, hormonal coil (Mirena, Kyleena) or patch/ring.
Current use or use in the last 3 months of any hormone replacement therapy (e.g. combined oestrogen and progesterone, oestrogen and Mirena coil combination, oestrogen alone if had a hysterectomy, or progesterone alone) or GnRH analogues use
On a selective serotonin reuptake inhibitor (SSRI) with a recent initiation or dose change within the last 3 months
Pregnant, breastfeeding or within 3 months post partum
Trial population
adults of reproductive age who experience menstrual cycles and have a diagnosis of, or symptoms consistent with, Premenstrual Dysphoric Disorder (PMDD) or a control population
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
blood level
progesterone
blood level
oestrogen
blood test
progesterone to oestrogen level
Sponsors and contacts
Click on the lead sponsor to view all of their trials.